Tomographic fluorescence mapping of tumor targets

Cancer Research

Volumn 65, Issue 14, 2005, Pages 6330-6336

  Montet, Xavier ^a   Ntziachristos, Vasilis ^a   Grimm, Jan ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PROTEIN TYROSINE KINASE; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; FLUORESCENCE; FLUORESCENCE MEDIATED TOMOGRAPHIC IMAGING SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TOMOGRAPHY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLUORESCENCE; GLIOSARCOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 22244458589     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0382     Document Type: Article

References (42)

1. Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intnwital microscopy. Nat Rev Cancer 2002;2:266-76.
2. Dewhirst MW Shan S, Cao Y, Moeller B, Yuan F, Li CY Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals. Dis Markers 2002;18:293-311.
3. Farkas S, Herfarth H, Rossle M, et al. Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice. Clin Exp Immunol 2001;126:250-8.
4. Halbhuber KJ, Konig K. Modern laser scanning microscopy in biology, biotechnology and medicine. Ann Anat 2003;185:1-20.
5. a. Hadjantonakis AK, Dickinson ME, Fraser SE, Papaioannou VE. Technicolour transgenics: imaging tools for functional genomics in the mouse. Nat Rev Genet 2003;4:613-25.
6. Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol 2003;21:1369-77.
7. Brown EB, Campbell RB, Tsuzuki Y, et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 2001;7:864-8.
8. von Andrian UH. Immunology. T cell activation in six dimensions. Science 2002;296:1815-7.
9. Kunneke S, Janshoff A. Visualization of molecular recognition events on microstructured lipid-membrane compartments by in situ scanning force microscopy. Angew Chem Int Ed Engl 2002;41:314-6.
10. Graves EE, Ripoll J, Weissleder R, Ntziachristos V. A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys 2003;30:901-11.
11. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000;97:2767-72.
12. Hawrysz DJ, Sevick-Muraca EM. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2000;2:388-417.
13. Arridge SR, Hebden JC. Optical imaging in medicine: II. Modelling and reconstruction. Phys Med Biol 1997;42;841-53.
14. Chang J, Graber HL, Harbour RL. Imaging of fluorescence in highly scattering media. IEEE Trans Biomed Eng 1997;44:810-22.
15. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001;7:743-8.
16. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002;8:757-60.
17. Farkas DL. Invention and commercialization in optical bioimaging. Nat Biotechnol 2003;21:1269-71.
18. Ballou B, Fisher GW, Hakala TR, Farkas DL. Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol Prog 1997;13:649-58.
19. Ballou B, Fisher GW, Deng JS, Hakala TR, Srivastava M, Farkas DL. Cyanine fluorochrome-labeled anti-bodies in vivo: assessment of tumor imaging using Cy3, Cy5, Cy5.5, and Cy7. Cancer Detect Prev 1998;22:251-7.
20. Tsien RY. Imagining imaging's future. Nat Rev Mol Cell Biol 2003; Suppl: SS16-21.
21. Zhang J, Campbell RE, Ting AY, Tsien RY. Creating new fluorescent probes for cell biology. Nat Rev Mol Cell Biol 2002;3:906-18.
22. Farkas DL, Du C, Fisher GW, et al. Non-invasive image acquisition and advanced processing in optical bioimaging. Comput Med Imaging Graph 1998;32:89-102.
23. Schulz RB, Ripoll J, Ntziachristos V. Noncontact optical tomography of turbid media. Opt Lett 2003;28:1701-3.
24. Ntziachristos V, Weissleder R. Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Opt Lett 2001;26:893-5.
25. Godavarty A, Thompson AB, Roy R, et al. Diagnostic imaging of breast cancer using fluorescence-enhanced optical tomography: phantom studies. J Biomed Opt 2004;9:488-96.
26. Ntziachristos V, Schellenberger EA, Ripoll J, et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an Annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004;101:12294-9.
27. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8.
28. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
29. Denis MC, Mahmood U, Benoist C, Mathis D, Weissleder R. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A 2004;101:12634-9.
30. Bremer C, Mustafa M, Bogdanov A Jr, Ntziachiistos V, Petrovsky A, Weissleder R, Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice. Radiology 2003;226:214-20.
31. Soubret A, Ntziachristos V. Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized born ratio. IEEE Trans Med Imag. In Press 2005.
32. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
33. Visscher DW, Smilanetz S, Drozdowicz S, Wykes SM. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal Quant Cytol Histol 1993;15:88-92.
34. Pearlman JD, Laham RJ, Post M, Leiner T, Simons M, Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesis. Curr Pharm Des 2002;8:1467-96.
35. Haubner RH, Wester HJ, Weber WA, Schwaiger M. Radiotracer-based strategies to image angiogenesis. Q J Nucl Med 2003;47:189-99.
36. Mordenti J, Thomsen K, Licko V, Chen H, Meng YG, Ferrara N. Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans. Toxicol Pathol 1999;27:14-21.
37. Lin YS, Nguyen C, Mendoza JL, et al. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J Pharmacol Exp Ther 1999;288:371-8.
38. Amin DN, Perkins AS, Stern DF. Gene expression profiling of ErbB receptor and ligand-dependent transcription. Oncogene 2004;23:1428-38.
39. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;3:443-53.
40. Sameni M, Dosescu J, Moin K, Sloane BF. Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis. Mol Imaging 2003;2:159-75.
41. Wetterwald A, van der Pluijm G, Que I, et al. Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 2002;160:1143-53.
42. Mahajan NP, Under K Berry G, Gordon GW, Heim R, Herman B. Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer. Nat Biotechnol 1998;16:547-52.